| Valproic acid | Approved Investigational | CDK14 | 5218 |
downregulated | Valproic Acid results in decreased expression of CDK14 mRNA | 7q21.13 | |
| Valproic acid | Approved Investigational | CDK16 | 5127 |
downregulated | Valproic Acid results in decreased expression of CDK16 mRNA | Xp11.3 | |
| Valproic acid | Approved Investigational | CDK19 | 23097 |
downregulated | Valproic Acid results in decreased expression of CDK19 mRNA | 6q21 | |
| Valproic acid | Approved Investigational | CDK2 | 1017 |
downregulated | Valproic Acid results in decreased expression of CDK2 mRNA | 12q13.2 | |
| Valproic acid | Approved Investigational | CDK2AP2 | 10263 |
upregulated | Valproic Acid results in increased expression of CDK2AP2 mRNA | 11q13.2 | |
| Valproic acid | Approved Investigational | CDK3 | 1018 |
downregulated | Valproic Acid results in decreased expression of CDK3 mRNA | 17q25.1 | |
| Valproic acid | Approved Investigational | CDK5 | 1020 |
upregulated | Valproic Acid results in increased expression of CDK5 mRNA | 7q36.1 | |
| Valproic acid | Approved Investigational | CDK5R2 | 8941 |
upregulated | Valproic Acid results in increased expression of CDK5R2 mRNA | 2q35 | |
| Valproic acid | Approved Investigational | CDK5RAP2 | 55755 |
downregulated | Valproic Acid results in decreased expression of CDK5RAP2 mRNA | 9q33.2 | |
| Valproic acid | Approved Investigational | CDK6 | 1021 |
downregulated | Valproic Acid results in decreased expression of CDK6 mRNA | 7q21.2 | |
| Valproic acid | Approved Investigational | CDK6 | 1021 |
upregulated | Valproic Acid results in increased expression of CDK6 mRNA | 7q21.2 | |
| Valproic acid | Approved Investigational | CDK7 | 1022 |
downregulated | Valproic Acid results in decreased expression of CDK7 mRNA | 5q13.2 | |
| Valproic acid | Approved Investigational | CDK8 | 1024 |
downregulated | Valproic Acid results in decreased expression of CDK8 mRNA | 13q12.13 | |
| Valproic acid | Approved Investigational | CDK9 | 1025 |
upregulated | Valproic Acid results in increased expression of CDK9 mRNA | 9q34.11 | |
| Valproic acid | Approved Investigational | CDKL2 | 8999 |
upregulated | Valproic Acid results in increased expression of CDKL2 mRNA | 4q21.1 | |
| Valproic acid | Approved Investigational | CDKL3 | 51265 |
downregulated | Valproic Acid results in decreased expression of CDKL3 mRNA | 5q31.1 | |
| Valproic acid | Approved Investigational | CDKN1A | 1026 |
upregulated | Valproic Acid results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Valproic acid | Approved Investigational | CDKN1B | 1027 |
downregulated | Valproic Acid results in decreased expression of CDKN1B mRNA | 12p13.1 | |
| Valproic acid | Approved Investigational | CDKN1C | 1028 |
downregulated | Valproic Acid results in decreased expression of CDKN1C mRNA | 11p15.4 | |
| Valproic acid | Approved Investigational | CDKN1C | 1028 |
upregulated | Valproic Acid results in increased expression of CDKN1C mRNA | 11p15.4 | |
| Valproic acid | Approved Investigational | CDKN2A | 1029 |
upregulated | Valproic Acid results in increased expression of CDKN2A mRNA | 9p21.3 | |
| Valproic acid | Approved Investigational | CDKN2AIP | 55602 |
downregulated | Valproic Acid results in decreased expression of CDKN2AIP mRNA | 4q35.1 | |
| Valproic acid | Approved Investigational | CDKN2AIPNL | 91368 |
downregulated | Valproic Acid results in decreased expression of CDKN2AIPNL mRNA | 5q31.1 | |
| Valproic acid | Approved Investigational | CDKN2B | 1030 |
upregulated | Valproic Acid results in increased expression of CDKN2B mRNA | 9p21.3 | |
| Valproic acid | Approved Investigational | CDKN2C | 1031 |
upregulated | Valproic Acid results in increased expression of CDKN2C mRNA | 1p32.3 | |